In German women aged 50–70, tomosynthesis plus synthesised 2D mammography did not significantly reduce 24-month invasive interval breast cancer versus digital mammography (14·2 vs 18·6 per 10 000 screen-negative women; OR 0·76, 95% CI 0·55–1·06).
RCTn = 98,755
Weigel et al. Invasive interval breast cancer rates after digital breast tomosynthesis plus synthesised mammography versus digital mammography screening (TOSYMA): 24-month follow-up of the multicentre, open-label, randomised, controlled, superiority trial